Tirzepatide showed a noninferior reduction in all-cause mortality (HR 0.88, 95% CI 0.68 to 1.16), myocardial infarction (HR 0.91, 95% CI 0.73 to 1.12) and stroke (HR 0.78, 95% CI 0.59 to 1.03) compared to dulaglutide, although CIs remained compatible with no difference
This could theoretically support blood glucose regulation and satiety, but should not be viewed as a replacement for established diabetes therapies
Doses above 2ml per injection show diminishing returns: a 2019 study published in the Journal of Clinical Endocrinology found no additional improvement in hepatic fat fraction when methionine doses exceeded 50mg per injection, and injection site soreness increased proportionally above this threshold
oleifera -treated animals exhibit increased levels of antioxidant markers such as CAT, delta-aminolevulinic acid dehydratase (ALAD), SOD, GPx, GSH, glucose-6-phosphatase (G-6-Pase), and total antioxidant capacity (TAC) (Chauhan et al
Williams is so caring and professional, very honest and takes time to address concerns
Measure beyond the scale